Suppression of unwanted CRISPR-Cas9 editing by co-administration of catalytically inactivating truncated guide RNAs
Numerous strategies exist to limit the off-target activity of CRISPR-Cas9 nucleases. Here the authors co-administer truncated gRNAs that block both Cas9 and high-fidelity Cas9 variants from cleaving at off-target sites.
Guardado en:
Autores principales: | John C. Rose, Nicholas A. Popp, Christopher D. Richardson, Jason J. Stephany, Julie Mathieu, Cindy T. Wei, Jacob E. Corn, Dustin J. Maly, Douglas M. Fowler |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/32953ad84ae148f1a96180fcc11e3524 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations
por: Grégoire Cullot, et al.
Publicado: (2019) -
Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing
por: Asmamaw M, et al.
Publicado: (2021) -
Engineering of CRISPR-Cas12b for human genome editing
por: Jonathan Strecker, et al.
Publicado: (2019) -
Editing of mouse and human immunoglobulin genes by CRISPR-Cas9 system
por: Taek-Chin Cheong, et al.
Publicado: (2016) -
Cas9 immunity creates challenges for CRISPR gene editing therapies
por: Julie M. Crudele, et al.
Publicado: (2018)